When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Type 2 diabetes in children

Última revisión: 17 Jan 2026
Última actualización: 26 Sep 2025

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • presence of risk factors
  • polyuria
  • polydipsia
  • acanthosis nigricans
  • nocturia
Todos los datos

Otros factores de diagnóstico

  • hypertension
  • yeast infections
  • skin infections
  • urinary tract infections
  • fatigue
  • blurred vision
  • weight loss
Todos los datos

Factores de riesgo

  • obesity
  • genetic predisposition/family history
  • high-risk ethnic background
  • puberty
  • female sex
  • diabetic in-utero environment
  • small for gestation age
  • rapid growth in infancy
  • bottle feeding
  • high protein intake in infancy
  • polycystic ovaries
  • intra-myocellular lipid content
  • fat deposition in the liver
  • learning disability
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • urine dipstick
  • random plasma glucose
  • fasting plasma glucose
  • HbA1c
  • autoantibodies to insulin, islet antigen 2 (IA-2), glutamic acid decarboxylase (GAD), and zinc transporter 8 (ZnT8)
Todos los datos

Pruebas diagnósticas que deben considerarse

  • 2-hour plasma glucose
  • random C-peptide
Todos los datos

Algoritmo de tratamento

AGUDA

ketoacidosis or hyperglycaemic hyperosmolar state (HHS)

CONTÍNUA

HbA1c <69 mmol/mol: no acidosis or ketosis

HbA1c ≥69 mmol/mol: no acidosis with or without ketosis

Colaboradores

Autores

Jennifer Miller, MD
Jennifer Miller

Professor

Department of Pediatrics

University of Florida

Gainesville

FL

Declarações

JM declares that she has received research funding from Soleno Therapeutics, Harmony Biosciences, and Rhythm Pharmaceuticals. JM is an author of a reference cited in this topic.

Chelsea Zimmerman, MD

Clinical Physician

Pediatric Endocrinology

Endocrinology and Metabolism of East Alabama

Opelika

AL

Declarações

CZ declares that she has no competing interests.

Agradecimentos

Dr Jennifer Miller and Dr Chelsea Zimmerman would like to gratefully acknowledge Dr Arlan Rosenbloom and Dr Paul Hiers, previous contributors to this topic.

Declarações

AR is an author of a number of references cited in this topic. Unfortunately, we have since been made aware that AR is deceased. PH declares that he has no competing interests.

Revisores

Philip Zeitler, MD, PhD

Professor of Pediatrics and Clinical Science

University of Colorado School of Medicine

Aurora

CO

Declarações

PZ declares that he has no competing interests.

Julian P. Hamilton-Shield, MB, ChB, MD(Bristol), MRCP, FRCPCH, FRCPCH

Professor

Diabetes and Metabolic Endocrinology

School of Clinical Sciences

University of Bristol

UK

Declarações

In the past, JPHS received speaking honoraria from Sanofi-Aventis, Roche, Abbott, Novo-Nordisk, and Nutricia. None of these talks were directly pertinent to the treatment of type 2 diabetes.

Kristen Nadeau, MD

Professor of Pediatric Endocrinology

University of Colorado School of Medicine

Aurora

CO

Declarações

KN declares that she has no competing interests.

Dennis Styne, MD

Professor of Pediatrics

Rumsey Chair of Pediatric Endocrinology

University of California

Sacramento

CA

Declarações

DS declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025 Jan;48(suppl 1):S1-352.Texto completo

Shah AS, Barrientos-Pérez M, Chang N, et al. ISPAD clinical practice consensus guidelines 2024: type 2 diabetes in children and adolescents. Horm Res Paediatr. 2024;97(6):555-83.Texto completo  Resumo

Glaser N, Fritsch M, Priyambada L, et al. ISPAD clinical practice consensus guidelines 2022: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022 Nov;23(7):835-56. Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Type 2 diabetes in children images
  • Diagnósticos diferenciais

    • Impaired glucose tolerance
    • Type 1 diabetes mellitus (T1DM)
    • Monogenic diabetes: maturity-onset diabetes of the young
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Type 2 diabetes in children and adolescents
    • Diabetes (type 1 and type 2) in children and young people: diagnosis and management
    Mais Diretrizes
  • Folhetos informativos para os pacientes

    Diabetes: what is it?

    Diabetes type 2: should I take insulin?

    Mais Folhetos informativos para os pacientes
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer